Amoxicillin: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "5 mg" to "5mg") |
Neil.m.young (talk | contribs) (Text replacement - "0 mg" to "0mg") |
||
| Line 9: | Line 9: | ||
===[[Strep Pharyngitis]]=== | ===[[Strep Pharyngitis]]=== | ||
* | *1000mg PO q24h x 10 days | ||
===[[Otitis Media]]=== | ===[[Otitis Media]]=== | ||
* | *1000mg PO q8h x 10 days | ||
===[[Sinusitis]]=== | ===[[Sinusitis]]=== | ||
* | *1000mg PO q8h x 10 days | ||
===[[Dental Abscess]]=== | ===[[Dental Abscess]]=== | ||
* | *1000mg PO x 1, then 500mg PO q8h x 3 days | ||
*If [[I&D]] | *If [[I&D]] | ||
===[[Chlamydial]] [[Cervicitis]]/[[Urethritis]]=== | ===[[Chlamydial]] [[Cervicitis]]/[[Urethritis]]=== | ||
* | *500mg PO q8h x 7 days | ||
*For pregnant patients | *For pregnant patients | ||
| Line 40: | Line 40: | ||
===Typhoid Fever=== | ===Typhoid Fever=== | ||
''Not 1st line treatment'' | ''Not 1st line treatment'' | ||
*50- | *50-100mg/kg/day PO divided q6-8h x 14 days | ||
*First Dose: 12.5mg-33.3 mg/kg PO x 1 | *First Dose: 12.5mg-33.3 mg/kg PO x 1 | ||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
===General=== | ===General=== | ||
*'''<3mo:''' 20- | *'''<3mo:''' 20-30mg/kg/day PO divided q12h | ||
**First Dose: 10-15mg/kg PO x 1 | **First Dose: 10-15mg/kg PO x 1 | ||
**Max: | **Max: 30mg/kg/day | ||
*'''>3mo:''' 25-45mg/kg/day PO divided q12h | *'''>3mo:''' 25-45mg/kg/day PO divided q12h | ||
**First Dose: 12.5-22.5mg/kg PO x 1 | **First Dose: 12.5-22.5mg/kg PO x 1 | ||
| Line 54: | Line 54: | ||
===[[Otitis Media]]=== | ===[[Otitis Media]]=== | ||
*'''<2 months''' | *'''<2 months''' | ||
** | **30mg/kg/day PO divided q12h x 10 days | ||
**First Dose: 15mg/kg PO x 1 | **First Dose: 15mg/kg PO x 1 | ||
*'''2 months - 5 years''' | *'''2 months - 5 years''' | ||
**80- | **80-90mg/kg/day PO divided q12h x 10 days | ||
**First Dose: 40-45mg/kg PO x 1 | **First Dose: 40-45mg/kg PO x 1 | ||
**Max: | **Max: 1000mg/dose | ||
*'''6-12 years''' | *'''6-12 years''' | ||
**80- | **80-90mg/kg/day PO divided q12h x 5-10 days | ||
**First Dose: 40-45mg/kg/day PO x 1 | **First Dose: 40-45mg/kg/day PO x 1 | ||
**Max: | **Max: 1000mg/dose | ||
===Community Acquired [[Pneumonia]]=== | ===Community Acquired [[Pneumonia]]=== | ||
* | *90mg/kg/day PO divided q12h x 5-10 days | ||
*First Dose: 45mg/kg PO x 1 | *First Dose: 45mg/kg PO x 1 | ||
**Max | **Max | ||
***3 months - 4 years: | ***3 months - 4 years: 500mg/dose | ||
***>5 years: | ***>5 years: 4000mg/day | ||
===[[Strep Pharyngitis]]=== | ===[[Strep Pharyngitis]]=== | ||
* | *50mg/kg Po q24h x 10 days | ||
*Max: | *Max: 1000mg/day | ||
===[[Sinusitis]]=== | ===[[Sinusitis]]=== | ||
* | *90mg/kg/day PO divided q8-12h x 10 days | ||
*Max: | *Max: 1000mg/dose | ||
===H. pylori=== | ===H. pylori=== | ||
* | *50mg/kg/day PO divided BID x 7-14 days | ||
*Max: | *Max: 2000mg/day | ||
===Early [[Lyme Disease]]=== | ===Early [[Lyme Disease]]=== | ||
* | *50mg/kg/day PO divided q8h x 14-21 days | ||
*First Dose: 16.6 mg/kg PO x1 | *First Dose: 16.6 mg/kg PO x1 | ||
*Max: | *Max: 500mg/dose | ||
===Salmonella (>3mo)=== | ===Salmonella (>3mo)=== | ||
*50- | *50-100mg/kg/day PO divided q8-12h | ||
**Acute: x 3-7 days | **Acute: x 3-7 days | ||
**Acute Immunocompromised: 10-14 days | **Acute Immunocompromised: 10-14 days | ||
| Line 97: | Line 97: | ||
===[[Typhoid Fever]] (>3mo)=== | ===[[Typhoid Fever]] (>3mo)=== | ||
''Not 1st line treatment'' | ''Not 1st line treatment'' | ||
*50- | *50-100mg/kg/day PO divided q6-8h x 14 days | ||
==Special Populations== | ==Special Populations== | ||
Revision as of 03:22, 19 July 2016
General
- Type: Amino-Penicillin
- Dosage Forms: 250, 500, 875; 125, 200, 250, 400/5 mL
- Common Trade Names: Amoxil; Moxatag
Adult Dosing
General
- 500-875mg PO q12
Strep Pharyngitis
- 1000mg PO q24h x 10 days
Otitis Media
- 1000mg PO q8h x 10 days
Sinusitis
- 1000mg PO q8h x 10 days
Dental Abscess
- 1000mg PO x 1, then 500mg PO q8h x 3 days
- If I&D
Chlamydial Cervicitis/Urethritis
- 500mg PO q8h x 7 days
- For pregnant patients
Lyme Disease
- 500mg PO q8h x 14-21 days
Salmonella
Not 1st line treatment
- Acute
- Immunocompetent
- 500mg PO q8h x 3-7 days
- Immunocompromised
- 1000mg PO q8h x 3-14 days
- Immunocompetent
- Chronic carrier
- 1000mg PO q8h x 3 months
Typhoid Fever
Not 1st line treatment
- 50-100mg/kg/day PO divided q6-8h x 14 days
- First Dose: 12.5mg-33.3 mg/kg PO x 1
Pediatric Dosing
General
- <3mo: 20-30mg/kg/day PO divided q12h
- First Dose: 10-15mg/kg PO x 1
- Max: 30mg/kg/day
- >3mo: 25-45mg/kg/day PO divided q12h
- First Dose: 12.5-22.5mg/kg PO x 1
- Max: 875mg/dose
Otitis Media
- <2 months
- 30mg/kg/day PO divided q12h x 10 days
- First Dose: 15mg/kg PO x 1
- 2 months - 5 years
- 80-90mg/kg/day PO divided q12h x 10 days
- First Dose: 40-45mg/kg PO x 1
- Max: 1000mg/dose
- 6-12 years
- 80-90mg/kg/day PO divided q12h x 5-10 days
- First Dose: 40-45mg/kg/day PO x 1
- Max: 1000mg/dose
Community Acquired Pneumonia
- 90mg/kg/day PO divided q12h x 5-10 days
- First Dose: 45mg/kg PO x 1
- Max
- 3 months - 4 years: 500mg/dose
- >5 years: 4000mg/day
- Max
Strep Pharyngitis
- 50mg/kg Po q24h x 10 days
- Max: 1000mg/day
Sinusitis
- 90mg/kg/day PO divided q8-12h x 10 days
- Max: 1000mg/dose
H. pylori
- 50mg/kg/day PO divided BID x 7-14 days
- Max: 2000mg/day
Early Lyme Disease
- 50mg/kg/day PO divided q8h x 14-21 days
- First Dose: 16.6 mg/kg PO x1
- Max: 500mg/dose
Salmonella (>3mo)
- 50-100mg/kg/day PO divided q8-12h
- Acute: x 3-7 days
- Acute Immunocompromised: 10-14 days
- Chronic: 3 months
Typhoid Fever (>3mo)
Not 1st line treatment
- 50-100mg/kg/day PO divided q6-8h x 14 days
Special Populations
- Pregnancy Rating: B
- Lactation: Use caution
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action:
Antibiotic Sensitivities[1]
Key
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- U sensitive for UTI only (non systemic infection)
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia
See Also
References
- ↑ Sanford Guide to Antimicrobial Therapy 2014
